Epidemiologic Survey of HBV, HCV and HIV Infections in a Pregnant Women Population in Central Nigeria: A Cross-Sectional Study
Victor B Oti, Isa H Mohammed, Yahaya Ibrahim, Chindo Ibrahim, Iboro Orok, Yakubu Y Saje, Attah A Ambrose and Muriana Olotu
Article Type: Research Article | First Published: February 27, 2021
Parallel and overlapping of HBV, HCV and HIV infections in pregnant women is a major public health problem. In this cross-sectional study, we evaluated the parallel and overlapping infections of HBV, HCV and HIV among pregnant women population in Keffi, Central Nigeria between June through August 2019. Four hundred (400) women blood specimens were collected from major Hospitals in Keffi for the study after informed consent and ethical approval were retrieved and a structured questionnaire was ad...
Identification and Comparison of Microbial Load of Different Water Products Available in Ekiti State
Akinseye Janet Funmilayo, Amadi Oyinyechi, Oluboyo Bernard Oluwapelumi, Akele Richard Yomi and Ayuba Sunday Buru
Article Type: Research Article | First Published: February 20, 2021
The quest for a safe drinking water free from any form of contamination cannot be overemphasized. People around the world do not have safe drinking water and that has resulted into myriad of water borne diseases. A total of twenty-two (22) samples were collected from twelve (12) different brand and subjected to microbiological analysis. From the results obtained, pH of the analyzed samples had ranges from 6.5 to 7.5, which fall within the normal standard range of 6.5 to 8.5. The Fecal coliform c...
The COVID-19 Burden or Tryptophan Syndrome: Autoimmunity, Immunoparalysis and Tolerance in a Tumorigenic Environment
Luiz Gonzaga Francisco de Assis Barros D’Elia Zanella and Luciana de Lima Galvão
Article Type: Review Article | First Published: February 27, 2021
SARS-CoV-2, a new virus, which has been causing the catastrophic pandemic in the world in 2020, triggers numerous physiologic changes in humans, with potentially fatal evolution due to COVID-19. COVID-19 can trigger immunoparalysis with deep and silent immunosuppression and a state of tolerance that may elicit opportunities for neoplastic transformation or latent infectious diseases. In addition, all neurologic or psychiatric symptoms have been observed - as clinically present in usual diseases,...
Effect of Hydroxychloroquine or Chloroquine and Azithromycin on COVID-19 Patients' Recovery and Mortality: Evidence from a Hospital Based Retrospective Cohort Study Conducted in Burkina Faso
Adama Baguiya, MD, Msc, Armel Poda, MD, Kadari Cissé, MD, Msc, Apoline K Sondo, MD, Boukary Ouedraogo, MD, PhD, Abdoul Risgou Ouedraogo, MD, Alfred B Tiono, MD, PhD, Pierre Kaboré, MD, Brice W Bicaba, MD, Msc, Jacques Zoungrana, MD, Adama Sourabié, MD, Souleymane Fofana, MD, Flavien Kaboré, MD, Adama Sanou, MD and Séni Kouanda, MD, PhD
Article Type: Original Research | First Published: February 15, 2021
Many countries have adopted hydroxychloroquine (HCQ) or chloroquine (CQ) and azithromycin (AZ) for the treatment of COVID-19 patients at the beginning of the pandemic and are still using them. The objective of this study was to measure the efficacy of CQ or HCQ and combined with AZ on patients' survival and recovery in Burkina Faso, West Africa. We conducted a hospital-based retrospective cohort study using routine data from all the hospitals involved in the COVID-19 response in Burkina Faso. Al...
Towards 90-90-90 Target: COVID-19 and HIV Response in Africa
Yusuff Adebayo Adebisi, Adrian Rabe, Aniekan Ekpenyong, Melody Okereke, Ouma Atieno Sarah, Oladunni Abimbola Amos, Alumuku Iordepuun Micheal, Amusile Olayemi, Damilola Quazeem Olaoye, Bamisaiye Adeola, Abdulhafeez Ayodele Mustapha and Don Eliseo Lucero- Prisno III
Article Type: Commentary | First Published: February 11, 2021
As cases of the novel coronavirus disease (COVID-19) continue to rise, so are the concerns of the effects this pandemic could have on people living with HIV. In response to the pandemic, measures have been put in place by African governments to limit the spread of the virus. We examine the impact of these measures on ensuring progress towards the HIV advocacy of “90-90-90” by 2020, i.e., 90% of all people living with HIV will know their status, 90% of people diagnosed will receive sustained ...